HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Ku-Geng Huo Selected Research
Ku-Geng Huo Research Topics
Disease
5
Hypertension (High Blood Pressure)
01/2022 - 05/2017
5
Vascular System Injuries
01/2022 - 05/2017
2
Lung Neoplasms (Lung Cancer)
01/2022 - 10/2020
2
Neoplasms (Cancer)
01/2022 - 01/2020
2
Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 01/2019
1
Pulmonary Tuberculosis
04/2024
1
Vascular Remodeling
01/2022
1
Adenocarcinoma of Lung
01/2022
1
Chronic Renal Insufficiency
01/2022
1
Atherosclerosis
01/2019
Drug/Important Bio-Agent (IBA)
4
Angiotensin II
IBA
01/2019 - 05/2017
3
MicroRNAs (MicroRNA)
IBA
01/2022 - 01/2019
2
Phosphotransferases (Kinase)
IBA
01/2022 - 01/2020
2
Messenger RNA (mRNA)
IBA
01/2022 - 01/2019
2
Angiotensins
IBA
12/2017 - 05/2017
1
Rifampin (Rifampicin)
FDA Link
Generic
04/2024
1
dabrafenib
IBA
01/2022
1
Vemurafenib
IBA
01/2022
1
Tyrosine Kinase Inhibitors
IBA
01/2022
1
trametinib
IBA
01/2022
1
Biomarkers (Surrogate Marker)
IBA
01/2020
1
Transcription Factors (Transcription Factor)
IBA
01/2019
1
Matrix Metalloproteinases (MMPs)
IBA
12/2017
1
Matrix Metalloproteinase 2 (Gelatinase A)
IBA
12/2017
1
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
05/2017
Therapy/Procedure
1
Therapeutics
10/2020